U.S. Will Pay Moderna $176 Million to Develop mRNA Bird Flu Vaccine

The United States government will pay vaccine manufacturer Moderna $176 million to develop a new mRNA vaccine to treat bird flu.

The U.S. Department of Health and Human Services will pay Moderna $176 million for a vaccine containing the same mRNA technology as the company’s COVID-19 vaccine.

Bird flu, or H5N1, has been reported in dairy cows and has infected three people in the United States.

In total, 135 dairy herds have been infected with bird flu in 12 states.

Per AP:

The U.S. government will pay the vaccine maker Moderna $176 million to develop a pandemic vaccine that could be used to treat bird flu in people as cases in dairy cows continue to mount across the country, federal officials announced Tuesday.

The funds are targeted for release through the U.S. Department of Health and Human Services and will pay for continued development of a vaccine that uses the same mRNA technology that allowed rapid development and rollout of vaccines to protect against COVID-19. The award was made through the Biomedical Advanced Research and Development Authority, or BARDA, a program focusing on medical treatments for potential pandemics.

Keep reading

Unknown's avatar

Author: HP McLovincraft

Seeker of rabbit holes. Pessimist. Libertine. Contrarian. Your huckleberry. Possibly true tales of sanity-blasting horror also known as abject reality. Prepare yourself. Veteran of a thousand psychic wars. I have seen the fnords. Deplatformed on Tumblr and Twitter.

Leave a comment